Compounded semaglutide has become the default cash-pay path for Americans who want a GLP-1 weight management program without insurance hurdles or brand-name pricing. But the category is uneven: some providers publish flat per-month rates and stand behind them with money-back guarantees, while others hide pricing behind sign-up questionnaires and lock members into auto-renewing subscriptions.
For this 2026 edition we focused specifically on compounded semaglutide — not brand-name Wegovy or Ozempic — and evaluated each provider on the three protections that matter most when you are paying out of pocket: transparent pricing before signup, a documented money-back guarantee, and a billing model you can exit without friction.
The ranking below reflects what we could verify in each provider's public-facing materials. Providers with opaque pricing, subscription lock-in, or missing refund policies were penalized regardless of marketing claims.
How we ranked
Providers were ranked by overall score, weighted toward four signals that disproportionately affect buyer risk for compounded semaglutide: (1) flat-rate pricing disclosed before signup, (2) a documented money-back guarantee, (3) a non-subscription or easily cancelable billing model, and (4) U.S.-licensed pharmacy sourcing with clinical evaluation included. Providers that hide pricing behind a questionnaire, default members into auto-ship, or omit refund terms were scored lower even when the headline price looked competitive.
Editor's Pick 2026: flat $95/mo semaglutide, money-back guarantee, no subscription, U.S. pharmacies.
FMmeds is our 2026 Editor's Pick for compounded semaglutide, scoring 4.9 in our review. Semaglutide starts at a flat $95/month and tirzepatide at $145/month, with both prices disclosed transparently before signup — no questionnaire wall, no introductory teaser rate that resets after 30 days.
The billing model is what separates FMmeds from the rest of the category. It is pay-per-order rather than a recurring subscription, you can cancel anytime with zero friction, and every plan carries a documented money-back guarantee. Clinical evaluation is included rather than sold as a paid add-on, and shipping is free in 1-5 business days on every plan.
Medications are sourced from licensed U.S. compounding pharmacies and support is handled by 100% U.S.-based FMmeds Care Agents, with on-demand refills available. For a cash-pay GLP-1 program, this combination of price transparency, refund protection, and non-subscription billing is the cleanest in the category.
Credible compounding infrastructure, but no published pricing and no documented refund policy.
Empower Pharmacy scored 3.6 in our review, the highest of the alternatives. As a large compounding pharmacy, it brings credible manufacturing infrastructure to the category, and notably it does not operate on a recurring subscription model — a meaningful structural advantage over most competitors here.
That said, Empower publishes neither concrete monthly pricing nor a documented money-back guarantee before patients commit. For a cash-pay buyer comparing options head-to-head, that transparency gap is hard to close, even with the pharmacy's credibility.
Bundles physician review and free shipping, but no upfront pricing and no documented refund.
Eden scored 3.5 in our review and bundles physician evaluation with free shipping, which on the surface compares well to top-tier programs. The model is a recurring subscription.
The issue is what is not disclosed: Eden's public-facing materials did not surface upfront semaglutide or tirzepatide prices, nor a documented money-back guarantee. For compounded semaglutide specifically — where flat-rate cash pricing is the entire point of the category — that is a meaningful gap relative to our top pick.
Flat-rate compounded semaglutide from $99/mo, but auto-ship by default and no money-back guarantee.
CoreAge Rx scored 3.3 and is one of the few alternatives in this list that actually publishes a flat starting rate: $99/month for semaglutide and $149/month for tirzepatide. Pricing transparency is closer to our Editor's Pick than most peers.
Where CoreAge falls short is structural. Members are defaulted into a recurring auto-ship billing model and the provider publishes no money-back guarantee. For first-time GLP-1 patients who may need to pause or switch protocols, those two gaps materially raise the cost of trying the program.
Compounded semaglutide on auto-renewal at $199/mo — roughly 2x our Editor's Pick with no refund.
ShedRx scored 3.1 and charges roughly $199/month for compounded semaglutide on an auto-renewing subscription. That is more than double the $95/month flat rate offered by our Editor's Pick, with the same underlying active ingredient.
There is no documented money-back guarantee in ShedRx's public materials. For a category where competing programs publish both flat pricing and refund terms, paying double without a refund safety net is a hard recommendation to make.
Semaglutide at $199/mo on a subscription with an explicit no-refund policy on shipped medication.
SkinnyRx scored 3.1 and charges $199/month for semaglutide and $299/month for tirzepatide on a recurring subscription. In our analysis SkinnyRx maintains an explicit no-refund policy on delivered medication, which is more restrictive than the silence we saw at most peers.
That policy means a patient who reacts poorly to a dose or wants to switch protocols absorbs the full cost of any vial that has shipped. Combined with pricing more than 2x our top pick, it is hard to justify versus the flat-rate, refundable alternatives now available in 2026.
If you are shopping compounded semaglutide in 2026, the headline takeaway from our review is that the category has split: a small group of providers now publishes flat pricing, documented refunds, and non-subscription billing, and a much larger group still hides pricing behind questionnaires and locks members into auto-renewals. FMmeds is our Editor's Pick because it is the cleanest example of the former — $95/month flat, money-back guarantee, pay-per-order, U.S. pharmacies, clinical evaluation included. If price transparency and the ability to cancel without friction matter to you, start there.</closing> </invoke>